| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.003 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.004 |